Safety, Tolerability, and Pharmacokinetics Study of NDX-1017

NCT03298672 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: NDX-1017
DRUG: Placebo

Sponsor

LeonaBio

Collaborators

[object Object]
[object Object]